NCT03351361
- Conditions
- Advanced Non Small Cell Lung Cancer
- Locations
-
- CH du Pays d'Aix Aix-en-Provence, France
- CHU d'Angers Angers, France
- CH de Beauvais Beauvais, France
- CHU de Brest Brest, France
Clinical trial condition
Advanced Non Small Cell Lung Cancer
Explore clinical trials studying Advanced Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
19 public trials
4 recruiting studies
Advanced Non Small Cell Lung Cancer trial results
NCT03326752
- Conditions
- Advanced Non Small Cell Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- Moores UC San Diego Cancer Center La Jolla, California, United States
- Ronald Reagan University of California Los Angeles Medical Center Santa Monica, California, United States
- Allina Health, Virginia Piper Cancer Institute Minneapolis, Minnesota, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Completed
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
NCT03652857
- Conditions
- Advanced Non Small Cell Lung Cancer
- Locations
-
- Hunan Provincal Tumor Hospital Changsha, Hunan, China
NCT00072631
- Conditions
- Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Institute for Drug Development Cancer Therapy and Research Center San Antonio, Texas, United States
NCT01631136
- Conditions
- Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Abbeville - CH Abbeville, France
- Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
- Clinique Claude Bernard Albi, France
- Annemasse - CH Ambilly, France
Active, Not Recruiting
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
NCT02143466
- Conditions
- Advanced Non Small Cell Lung Cancer
- Locations
-
- Research Site Atlanta, Georgia, United States
- Research Site Boston, Massachusetts, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
Active, Not Recruiting
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
NCT04940325
- Conditions
- Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Institut Bergonié Bordeaux, France
- Institut de Cancérologie, CHRU Morvan de Brest Brest, France
- Centre François Baclesse Caen, France
- Centre Hospitalier Intercommunal de Créteil Créteil, France
Active, Not Recruiting
A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
NCT05318573
- Conditions
- Advanced Non Small Cell Lung Cancer, Advanced Urothelial Carcinoma
- Locations
-
- Cancer and Blood Speciality Clinic Long Beach, California, United States
- Sharp Memorial Hospital (Oncology Clinical Research) San Diego, California, United States
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
Active, Not Recruiting
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
NCT04685135
- Conditions
- Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
- Local Institution - 012-898 Cerritos, California, United States
- City of Hope - Duarte (Main Campus) Duarte, California, United States
- Local Institution - 012-898 D Glendale, California, United States
- Local Institution - 012-910-A Huntington Beach, California, United States